F
Frederik L. Giesel
Researcher at University Hospital Heidelberg
Publications - 311
Citations - 17455
Frederik L. Giesel is an academic researcher from University Hospital Heidelberg. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 53, co-authored 255 publications receiving 12258 citations. Previous affiliations of Frederik L. Giesel include German Cancer Research Center & Heidelberg University.
Papers
More filters
Journal ArticleDOI
3D printing based on imaging data: review of medical applications
Fabian Rengier,Fabian Rengier,Amit Mehndiratta,Amit Mehndiratta,H. von Tengg-Kobligk,H. von Tengg-Kobligk,Christian M. Zechmann,Christian M. Zechmann,Roland Unterhinninghofen,H. U. Kauczor,Frederik L. Giesel,Frederik L. Giesel +11 more
TL;DR: Medical application of rapid prototyping is feasible for specialized surgical planning and prosthetics applications and has significant potential for development of new medical applications.
Journal ArticleDOI
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh,Eleni Avtzi,Frederik L. Giesel,Tim Holland-Letz,Heinz G. Linhart,Matthias Eder,Michael Eisenhut,Silvan Boxler,Boris Hadaschik,Clemens Kratochwil,Wilko Weichert,Klaus Kopka,Jürgen Debus,Uwe Haberkorn +13 more
TL;DR: 68Ga-PSMA-ligand PET/CT can detect recurrent PCa in a high number of patients and can help delay systemic therapy of PCa.
Journal ArticleDOI
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh,Christian M. Zechmann,Anna Malcher,Matthias Eder,Michael Eisenhut,Heinz G. Linhart,Tim Holland-Letz,Boris Hadaschik,Frederik L. Giesel,Jürgen Debus,Uwe Haberkorn +10 more
TL;DR: 68Ga-PSMA PET/CT can detect lesions characteristic for PC with improved contrast when compared to standard 18F-fluoromethylcholine PET/ CT, especially at low PSA levels.
Journal ArticleDOI
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil,Paul Flechsig,Thomas Lindner,Labidi Abderrahim,Annette Altmann,Annette Altmann,Walter Mier,Sebastian Adeberg,Hendrik Rathke,Manuel Röhrich,Hauke Winter,Peter K. Plinkert,Frederik Marmé,Matthias Lang,Hans-Ulrich Kauczor,Dirk Jäger,Dirk Jäger,Jürgen Debus,Jürgen Debus,Uwe Haberkorn,Uwe Haberkorn,Frederik L. Giesel +21 more
TL;DR: The high and rather selective tumor uptake on 68Ga-FAPI PET/CT may open up new applications for noninvasive tumor characterization, staging examinations, or radioligand therapy.
Journal ArticleDOI
225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer.
Clemens Kratochwil,Frank Bruchertseifer,Frederik L. Giesel,Mirjam Weis,Frederik A. Verburg,Felix M. Mottaghy,Klaus Kopka,Christos Apostolidis,Uwe Haberkorn,Alfred Morgenstern +9 more
TL;DR: Targeted α-therapy with 225Ac-PSMA-617, although still experimental, obviously has strong potential to significantly benefit advanced-stage prostate cancer patients.